Anavex Life Sciences Corp. Financials
AVXL
All currency values in $ millions unless otherwise noted
Scroll
| Income Statement | SEP 2025 | SEP 2024 | SEP 2023 | SEP 2022 | SEP 2021 |
|---|---|---|---|---|---|
| General & Administrative | $14 | $11 | $12 | $13 | $9 |
| Research & Development | $38 | $42 | $44 | $38 | $33 |
| Total Operating Expenses | $51 | $53 | $56 | $51 | $42 |
| Operating Income | -$51 | -$53 | -$56 | -$51 | -$42 |
| Other Non-Operating Income (Expense) | $5 | $10 | $8 | $2 | $4 |
| EBT (Earnings Before Tax) | -$46 | -$43 | -$47 | -$48 | -$38 |
| Net Income | |||||
| Net Income | -$46 | -$43 | -$48 | -$48 | -$38 |
| EPS (Basic) | -$0.54 | -$0.52 | -$0.60 | -$0.62 | -$0.54 |
| EPS (Diluted) | -$0.54 | -$0.52 | -$0.60 | -$0.62 | -$0.54 |
| Weighted Avg Shares (Basic) | 85.3M | 83.5M | 79.8M | 76.9M | 69.8M |
| Weighted Avg Shares (Diluted) | 85.3M | 83.5M | 79.8M | 76.9M | 69.8M |
| Shares Outstanding | 85.3M | 83.5M | 79.8M | 76.9M | 69.8M |
Anavex Life Sciences (AVXL) financials: revenue, profit and margins
Anavex Life Sciences (AVXL) generated about n/a in revenue and -$13 million in net income over the trailing twelve months. Figures are from SEC filings; this is analysis, not investment advice.
Frequently asked
Is Anavex Life Sciences profitable?+
Anavex Life Sciences reported about -$13 million in net loss over the trailing twelve months. Net income is the bottom line after all costs, interest and taxes. Compare it to free cash flow on this tab, since reported profit and actual cash generated can diverge.
SourceFinancial statements computed from the 10-Q filed 28 Aug 2026, covering the period ending 30 Jun 2026, as reported to the SEC. Data last refreshed 12 Oct 2026. How this is calculated.
Fiscal year ends Sep.
Peers
Biological Products, (No Diagnostic Substances) · Pick stocks to compare with AVXL
Held by ETFs
AVXL is in 9 US ETFs. The largest of them, with AVXL's weight in each:
Spot a number that looks wrong? Check it in AVXL's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing AVXL
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.